Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
01 2Phyton Biotech LLC
02 2SERIPHARM
03 1Chongqing Sintaho Pharmaceutical Co., Ltd.
04 1Aurobindo Pharma Limited
05 1Bamboo US Bidco LCC
06 1Corden Pharma Boulder, Inc.
07 1Fujian South Pharmaceutical Co. Ltd.
08 1Hetero Labs Limited
09 4Indena SpA
10 1MSN Laboratories Private Limited
11 2ScinoPharm Taiwan Ltd.
12 1TAPI Czech Industries s.r.o.
13 1Teva Czech Industries s.r.o
14 1Yung Shin Pharmaceutical Ind. Co., Ltd.
15 1Yunnan Hande Bio-Tech Co., Ltd.
01 5PACLITAXEL
02 13Paclitaxel
03 2Paclitaxel Semisynthetic
04 1paclitaxel
01 2Canada
02 4China
03 3Germany
04 3India
05 1Israel
06 4Italy
07 2Taiwan
08 2Blank
Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
NDC Package Code : 51446-0110
Start Marketing Date : 2011-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Axplora- The partner of choice for complex APIs.
NDC Package Code : 62422-0002
Start Marketing Date : 1996-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Chongqing Sintaho Pharma: A trusted partner globally for chemosynthetic APIs.
NDC Package Code : 84172-111
Start Marketing Date : 2024-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (1g/g)
Marketing Category : BULK INGREDIENT
Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
NDC Package Code : 51446-0120
Start Marketing Date : 2012-11-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Axplora- The partner of choice for complex APIs.
NDC Package Code : 62422-0004
Start Marketing Date : 1996-12-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42533-111
Start Marketing Date : 2002-05-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (4kg/4kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-3055
Start Marketing Date : 2013-01-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-4040
Start Marketing Date : 2002-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-4055
Start Marketing Date : 2007-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-4056
Start Marketing Date : 2020-04-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A OncoGel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of OncoGel, including repackagers and relabelers. The FDA regulates OncoGel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. OncoGel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of OncoGel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A OncoGel supplier is an individual or a company that provides OncoGel active pharmaceutical ingredient (API) or OncoGel finished formulations upon request. The OncoGel suppliers may include OncoGel API manufacturers, exporters, distributors and traders.
click here to find a list of OncoGel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing OncoGel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for OncoGel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture OncoGel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain OncoGel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a OncoGel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of OncoGel suppliers with NDC on PharmaCompass.
We have 13 companies offering OncoGel
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
